For: | Tack GJ, Verbeek WH, Al-Toma A, Kuik DJ, Schreurs MW, Visser O, Mulder CJ. Evaluation of Cladribine treatment in refractory celiac disease type II. World J Gastroenterol 2011; 17(4): 506-513 [PMID: 21274381 DOI: 10.3748/wjg.v17.i4.506] |
---|---|
URL: | https://www.wjgnet.com/1007-9327/full/v17/i4/506.htm |
Number | Citing Articles |
1 |
Adam C. Bledsoe, Joseph A. Murray. Diagnosis and Management of Gluten-Associated Disorders. 2021; : 115 doi: 10.1007/978-3-030-56722-4_10
|
2 |
Richa Chibbar, Jordan Nostedt, Dana Mihalicz, Jean Deschenes, Ross McLean, Levinus A. Dieleman. Refractory Celiac Disease Type II: A Case Report and Literature Review. Frontiers in Medicine 2020; 7 doi: 10.3389/fmed.2020.564875
|
3 |
Craig R. Soderquist, Govind Bhagat. Immunopathology of Celiac Disease. International Review of Cell and Molecular Biology 2021; 358: 207 doi: 10.1016/bs.ircmb.2020.12.001
|
4 |
Georgia Malamut, Craig R. Soderquist, Govind Bhagat, Nadine Cerf-Bensussan. Advances in Nonresponsive and Refractory Celiac Disease. Gastroenterology 2024; doi: 10.1053/j.gastro.2024.02.048
|
5 |
Antonio Di Sabatino, Federico Biagi, Paolo G. Gobbi, Gino R. Corazza. How I treat enteropathy-associated T-cell lymphoma. Blood 2012; 119(11): 2458 doi: 10.1182/blood-2011-10-385559
|
6 |
Filippo Pelizzaro, Ilaria Marsilio, Matteo Fassan, Francesco Piazza, Brigida Barberio, Anna D’Odorico, Edoardo V. Savarino, Fabio Farinati, Fabiana Zingone. The Risk of Malignancies in Celiac Disease—A Literature Review. Cancers 2021; 13(21): 5288 doi: 10.3390/cancers13215288
|
7 |
Luis Vaquero, Laura Rodríguez-Martín, Francisco León, Francisco Jorquera, Santiago Vivas. New coeliac disease treatments and their complications. Gastroenterología y Hepatología (English Edition) 2018; 41(3): 191 doi: 10.1016/j.gastre.2018.03.007
|
8 |
Marco Valvano, Stefano Fabiani, Sabrina Monaco, Mauro Calabrò, Antonio Mancusi, Sara Frassino, Claudia Rolandi, Marta Mosca, Susanna Faenza, Emanuele Sgamma, Nicola Cesaro, Giovanni Latella. Old and New Adjunctive Therapies in Celiac Disease and Refractory Celiac Disease: A Review. International Journal of Molecular Sciences 2023; 24(16): 12800 doi: 10.3390/ijms241612800
|
9 |
Ikram Nasr, Iman Nasr, Carl Beyers, Fuju Chang, Suzanne Donnelly, Paul Ciclitira. Recognising and Managing Refractory Coeliac Disease: A Tertiary Centre Experience. Nutrients 2015; 7(12): 9896 doi: 10.3390/nu7125506
|
10 |
Rupa Mukherjee, Ciaran P. Kelly, Detlef Schuppan. Nondietary Therapies for Celiac Disease. Gastrointestinal Endoscopy Clinics of North America 2012; 22(4): 811 doi: 10.1016/j.giec.2012.09.001
|
11 |
Marko Weber, Nina Wolf, Federica Branchi, Paul Tangermann, Alice Itzlinger, Lukas Poralla, Jan C. Preiß, Philip Grunert, Severin Daum, Britta Siegmund, Andreas Stallmach, Michael Schumann. Results from the German registry for refractory celiac disease. Zeitschrift für Gastroenterologie 2021; 59(09): 944 doi: 10.1055/a-1540-7476
|
12 |
Abdulbaqi Al-toma, Petula Nijeboer, Gerd Bouma, Otto Visser, Chris JJ Mulder. Hematopoietic stem cell transplantation for non-malignant gastrointestinal diseases. World Journal of Gastroenterology 2014; 20(46): 17368-17375 doi: 10.3748/wjg.v20.i46.17368
|
13 |
Roy L.J. van Wanrooij, Hetty J. Bontkes, E. Andra Neefjes-Borst, Chris J. Mulder, Gerd Bouma. Immune-mediated enteropathies: From bench to bedside. Journal of Autoimmunity 2021; 118: 102609 doi: 10.1016/j.jaut.2021.102609
|
14 |
Julie Zhu, Chris J J Mulder, Levinus A Dieleman. Celiac Disease: Against the Grain in Gastroenterology. Journal of the Canadian Association of Gastroenterology 2019; 2(4): 161 doi: 10.1093/jcag/gwy042
|
15 |
|
16 |
Craig R. Soderquist, Suzanne K. Lewis, Alejandro A. Gru, George Vlad, Eli S. Williams, Susan Hsiao, Mahesh M. Mansukhani, David C. Park, Carlos E. Bacchi, Bachir Alobeid, Peter H. Green, Govind Bhagat. Immunophenotypic Spectrum and Genomic Landscape of Refractory Celiac Disease Type II. American Journal of Surgical Pathology 2021; 45(7): 905 doi: 10.1097/PAS.0000000000001658
|
17 |
|
18 |
Christopher S. McAllister, Martin F. Kagnoff. The immunopathogenesis of celiac disease reveals possible therapies beyond the gluten-free diet. Seminars in Immunopathology 2012; 34(4): 581 doi: 10.1007/s00281-012-0318-8
|
19 |
Petula Nijeboer, Roy L. J. van Wanrooij, Greetje J. Tack, Chris J. J. Mulder, Gerd Bouma. Update on the Diagnosis and Management of Refractory Coeliac Disease. Gastroenterology Research and Practice 2013; 2013: 1 doi: 10.1155/2013/518483
|
20 |
Clemens Warnke, Verena I. Leussink, Norbert Goebels, Orhan Aktas, Alexey Boyko, Bernd C. Kieseier, Hans-Peter Hartung. Cladribine as a therapeutic option in multiple sclerosis. Clinical Immunology 2012; 142(1): 68 doi: 10.1016/j.clim.2011.05.009
|
21 |
Alexandra Fernandes, Ana Margarida Ferreira, Rosa Ferreira, Sofia Mendes, Cláudia Agostinho, Nuno Almeida, Pedro Figueiredo, Manuela Ferreira, Pedro Amaro, Lígia Prado e Castro, Carlos Sofia. Refractory Celiac Disease Type II: A Case Report that Demonstrates the Diagnostic and Therapeutic Challenges. GE Portuguese Journal of Gastroenterology 2016; 23(2): 106 doi: 10.1016/j.jpge.2015.08.001
|
22 |
Yvonne M. C. Kooy-Winkelaar, Dagmar Bouwer, George M. C. Janssen, Allan Thompson, Martijn H. Brugman, Frederike Schmitz, Arnoud H. de Ru, Tom van Gils, Gerd Bouma, Jon J. van Rood, Peter A. van Veelen, M. Luisa Mearin, Chris J. Mulder, Frits Koning, Jeroen van Bergen. CD4 T-cell cytokines synergize to induce proliferation of malignant and nonmalignant innate intraepithelial lymphocytes. Proceedings of the National Academy of Sciences 2017; 114(6) doi: 10.1073/pnas.1620036114
|
23 |
Jeske van Pamelen, Lynn van Olst, Andries E Budding, Helga E de Vries, Leo H Visser. Alterations of Gut Microbiota and the Brain-Immune-Intestine Axis in Patients With Relapsing-Remitting Multiple Sclerosis After Treatment With Oral Cladribine: Protocol for a Prospective Observational Study. JMIR Research Protocols 2020; 9(7): e16162 doi: 10.2196/16162
|
24 |
Luca Elli, Pietro Soru, Leda Roncoroni, Francesca Gaia Rossi, Valeria Ferla, Luca Baldini, Nicoletta Nandi, Lucia Scaramella, Alice Scricciolo, Alessandro Rimondi, Nicola Fusco, Giorgio Alberto Croci, Umberto Gianelli, Lilla Cro, Marzia Barbieri, Vincenza Lombardo, Andrea Costantino, Valentina Vaira, Stefano Ferrero, Gian Eugenio Tontini, Giulio Barigelletti, Sabrina Fabiano, Luisa Doneda, Maurizio Vecchi. Clinical features of type 1 and 2 refractory celiac disease: Results from a large cohort over a decade. Digestive and Liver Disease 2023; 55(2): 235 doi: 10.1016/j.dld.2022.08.022
|
25 |
Jörg Felber, Hendrik Bläker, Wolfgang Fischbach, Sibylle Koletzko, Martin Laaß, Nils Lachmann, Pia Lorenz, Petra Lynen, Imke Reese, Katharina Scherf, Detlef Schuppan, Michael Schumann, D. Aust, S. Baas, S. Beisel, J. de Laffolie, E. Duba, W. Holtmeier, L. Lange, C. Loddenkemper, G. Moog, T. Rath, E. Roeb, D. Rubin, J. Stein, H. Török, Y. Zopf. Aktualisierte S2k-Leitlinie Zöliakie der Deutschen Gesellschaft für Gastroenterologie, Verdauungs- und Stoffwechselkrankheiten (DGVS). Zeitschrift für Gastroenterologie 2022; 60(05): 790 doi: 10.1055/a-1741-5946
|
26 |
Federica Branchi, Jakob Johann Wiese, Claudia Heldt, Subhakankha Manna, Violaine Dony, Christoph Loddenkemper, Christian Bojarski, Britta Siegmund, Thomas Schneider, Severin Daum, Michael Hummel, Verena Moos, Michael Schumann. The combination of clinical parameters and immunophenotyping of intraepithelial lymphocytes allows to assess disease severity in refractory celiac disease. Digestive and Liver Disease 2022; 54(12): 1649 doi: 10.1016/j.dld.2022.06.024
|
27 |
Petula Nijeboer, Georgia Malamut, Gerd Bouma, Nadine Cerf-Bensussan, Frits Koning, Jeroen van Bergen, Christophe Cellier, Chris J.J. Mulder. Therapy in RCDII: Rationale for Combination Strategies?. Digestive Diseases 2015; 33(2): 227 doi: 10.1159/000381076
|
28 |
Jeremy Woodward. The management of refractory coeliac disease. Therapeutic Advances in Chronic Disease 2013; 4(2): 77 doi: 10.1177/2040622312473174
|
29 |
Elisabeth Megan Rose Baggus, Marios Hadjivassiliou, Simon Cross, Hugo Penny, Heidi Urwin, Sarah Watson, Jeremy Mark Woodward, David S Sanders. How to manage adult coeliac disease: perspective from the NHS England Rare Diseases Collaborative Network for Non-Responsive and Refractory Coeliac Disease. Frontline Gastroenterology 2020; 11(3): 235 doi: 10.1136/flgastro-2019-101191
|
30 |
Jolanda MW van de Water, Petula Nijeboer, Laura R de Baaij, Jessy Zegers, Gerd Bouma, Otto J Visser, Donald L van der Peet, Chris JJ Mulder, Wilhelmus JHJ Meijerink. Surgery in (pre)malignant celiac disease. World Journal of Gastroenterology 2015; 21(43): 12403-12409 doi: 10.3748/wjg.v21.i43.12403
|
31 |
|
32 |
Satya Kurada, Abhijeet Yadav, Daniel A. Leffler. Current and novel therapeutic strategies in celiac disease. Expert Review of Clinical Pharmacology 2016; 9(9): 1211 doi: 10.1080/17512433.2016.1200463
|
33 |
Manjeet Kumar Goyal. Comments on "Enduring Clinical Remission in Refractory Celiac Disease Type II with Tofacitinib: An Open-Label Clinical Study". Clinical Gastroenterology and Hepatology 2024; doi: 10.1016/j.cgh.2024.07.004
|
34 |
J. G. Burkhardt, A. Chapa‐Rodriguez, S. L. Bahna. Gluten sensitivities and the allergist: Threshing the grain from the husks. Allergy 2018; 73(7): 1359 doi: 10.1111/all.13354
|
35 |
Stefania Chetcuti Zammit, David S. Sanders, Reena Sidhu. Refractory coeliac disease: what should we be doing different?. Current Opinion in Gastroenterology 2020; 36(3): 215 doi: 10.1097/MOG.0000000000000628
|
36 |
Petula Nijeboer, Tom van Gils, Martine Reijm, Rogier Ooijevaar, Birgit I. Lissenberg-Witte, Hetty J. Bontkes, Chris J.J. Mulder, Gerd Bouma. Gamma-Delta T Lymphocytes in the Diagnostic Approach of Coeliac Disease. Journal of Clinical Gastroenterology 2019; 53(5): e208 doi: 10.1097/MCG.0000000000001060
|
37 |
Hugo A. Penny, Elisabeth M. R. Baggus, Anupam Rej, John A. Snowden, David S. Sanders. Non-Responsive Coeliac Disease: A Comprehensive Review from the NHS England National Centre for Refractory Coeliac Disease. Nutrients 2020; 12(1): 216 doi: 10.3390/nu12010216
|
38 |
Matthew J. Armstrong, Vinod S. Hegade, Gerry Robins. Advances in coeliac disease. Current Opinion in Gastroenterology 2012; 28(2): 104 doi: 10.1097/MOG.0b013e32834d0844
|
39 |
R. L. J. van Wanrooij, D. M. J. Müller, E. A. Neefjes-Borst, J. Meijer, L. G. Koudstaal, D. A. M. Heideman, H. J. Bontkes, B. M. E. von Blomberg, G. Bouma, C. J. J. Mulder. Optimal Strategies to Identify Aberrant Intra-Epithelial Lymphocytes in Refractory Coeliac Disease. Journal of Clinical Immunology 2014; 34(7): 828 doi: 10.1007/s10875-014-0075-7
|
40 |
Ikram Nasr, Iman Nasr, Hannah Campling, Paul J. Ciclitira. Approach to patients with refractory coeliac disease. F1000Research 2016; 5: 2544 doi: 10.12688/f1000research.9051.1
|
41 |
|
42 |
Greetje J. Tack, Roy L.J. van Wanrooij, Anton W. Langerak, Jennifer M.L. Tjon, B. Mary E. von Blomberg, Danielle A.M. Heideman, Jeroen van Bergen, Frits Koning, Gerd Bouma, Chris J.J. Mulder, Marco W.J. Schreurs. Origin and immunophenotype of aberrant IEL in RCDII patients. Molecular Immunology 2012; 50(4): 262 doi: 10.1016/j.molimm.2012.01.014
|
43 |
Peter Koehler, Herbert Wieser, Katharina Konitzer. Celiac Disease and Gluten. 2014; : 1 doi: 10.1016/B978-0-12-420220-7.00001-8
|
44 |
Tom van Gils, Petula Nijeboer, Roy L. van Wanrooij, Gerd Bouma, Chris J. J. Mulder. Mechanisms and management of refractory coeliac disease. Nature Reviews Gastroenterology & Hepatology 2015; 12(10): 572 doi: 10.1038/nrgastro.2015.155
|
45 |
Tom van Gils, Petula Nijeboer, Jan Hein TM van Waesberghe, Veerle MH Coupé, Kiki Janssen, Jessy A Zegers, Shaikh A Nurmohamed, Georg Kraal, Sabine CI Jiskoot, Gerd Bouma, Chris JJ Mulder. Splenic volume differentiates complicated and non‐complicated celiac disease. United European Gastroenterology Journal 2017; 5(3): 374 doi: 10.1177/2050640616663571
|
46 |
Luis Vaquero, Laura Rodríguez-Martín, Francisco León, Francisco Jorquera, Santiago Vivas. Nuevas terapias en la enfermedad celiaca y sus complicaciones. Gastroenterología y Hepatología 2018; 41(3): 191 doi: 10.1016/j.gastrohep.2017.12.002
|
47 |
Hugo A Penny, Annalisa Schiepatti, David S Sanders. Coeliac Disease and Gluten-Related Disorders. 2022; : 87 doi: 10.1016/B978-0-12-821571-5.00005-2
|
48 |
Pardeep Kumar Maheshwari, Iain Feeley, Hilary Oleary, Carol Goulding. A 37-year-old woman with refractory coeliac disease type II disease treated by stem cell transplantation. BMJ Case Reports 2015; : bcr2015209363 doi: 10.1136/bcr-2015-209363
|
49 |
Isabel A. Hujoel, Joseph A. Murray. Refractory Celiac Disease. Current Gastroenterology Reports 2020; 22(4) doi: 10.1007/s11894-020-0756-8
|
50 |
Alberto Rubio-Tapia, Ivor D Hill, Ciarán P Kelly, Audrey H Calderwood, Joseph A Murray. ACG Clinical Guidelines: Diagnosis and Management of Celiac Disease. American Journal of Gastroenterology 2013; 108(5): 656 doi: 10.1038/ajg.2013.79
|
51 |
P Nijeboer, RLJ van Wanrooij, T van Gils, NJ Wierdsma, GJ Tack, BI Witte, HJ Bontkes, O Visser, CJJ Mulder, G Bouma. Lymphoma development and survival in refractory coeliac disease type II: Histological response as prognostic factor. United European Gastroenterology Journal 2017; 5(2): 208 doi: 10.1177/2050640616646529
|
52 |
|
53 |
Peter H.R. Green, Shirley Paski, Cynthia W. Ko, Alberto Rubio-Tapia. AGA Clinical Practice Update on Management of Refractory Celiac Disease: Expert Review. Gastroenterology 2022; 163(5): 1461 doi: 10.1053/j.gastro.2022.07.086
|
54 |
Roy L.J. van Wanrooij, E. Andra Neefjes-Borst, Hetty J. Bontkes, Marco W.J. Schreurs, Anton W. Langerak, Chris J.J. Mulder, Gerd Bouma. Adult-Onset Autoimmune Enteropathy in an European Tertiary Referral Center. Clinical and Translational Gastroenterology 2021; 12(8): e00387 doi: 10.14309/ctg.0000000000000387
|
55 |
Tessa Dieckman, Michael Schumann, Hanneke Beaumont, Hetty J. Bontkes, Frits Koning, Gerd Bouma, Valerie Byrnes, Jane McCarthy, Andra Neefjes-Borst, Christoph Loddenkemper, Jeroen van Bergen, Marlous op de Weegh, K.E.A. Lundin. Enduring Clinical Remission in Refractory Celiac Disease Type II with Tofacitinib: An Open-Label Clinical Study. Clinical Gastroenterology and Hepatology 2024; doi: 10.1016/j.cgh.2024.05.022
|